Reference
Chan RT-T. Afatinib for an EGFR exon 20 insertion mutation: A case report of progressive stage IV metastatic lung adenocarcinoma with 54 months' survival. Asia-Pacific Journal of Clinical Oncology 14 (Suppl. 1): 7-9, Mar 2018. Available from: URL: http://doi.org/10.1111/ajco.12853 - Hong Kong
Rights and permissions
About this article
Cite this article
Afatinib/carboplatin/pemetrexed. Reactions Weekly 1697, 21 (2018). https://doi.org/10.1007/s40278-018-44577-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44577-0